 TEG will be compared to these additional coagulation assays to determine whether prolongation of R time the most sensitive measurement of coagulation factor activity and other TEG parameters can be utilized as reliable measurements of Rivaroxaban activity. Each of these tests will be performed at the two aforementioned timepoints: admission and post reversal or 24 hours post admission if clinical team does not opt to reverse patent. 